These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16197287)
1. Homocysteine and vascular disease in diabetes: a double hit? Huijberts MS; Becker A; Stehouwer CD Clin Chem Lab Med; 2005; 43(10):993-1000. PubMed ID: 16197287 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of homocysteine as a risk factor in diabetes. Becker A; Smulders YM; van Guldener C; Stehouwer CD Metab Syndr Relat Disord; 2003 Jun; 1(2):105-20. PubMed ID: 18370632 [TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and hyperhomocysteinemia. van Guldener C; Stehouwer CD Semin Vasc Med; 2002 Feb; 2(1):87-95. PubMed ID: 16222599 [TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine and microvascular complications in type 1 diabetes. Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between plasma homocysteine and chronic complications in type 2 diabetes mellitus]. Li WP; Li W; Yang T Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):349-50. PubMed ID: 15772011 [TBL] [Abstract][Full Text] [Related]
6. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051 [TBL] [Abstract][Full Text] [Related]
7. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M; Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016 [TBL] [Abstract][Full Text] [Related]
8. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
9. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187 [TBL] [Abstract][Full Text] [Related]
10. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489 [TBL] [Abstract][Full Text] [Related]
11. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease. Moat SJ; Bonham JR; Powers HJ Clin Sci (Lond); 2001 Jan; 100(1):73-9. PubMed ID: 11115421 [TBL] [Abstract][Full Text] [Related]
12. Total plasma homocysteine is associated with hypertension in Type I diabetic patients. Neugebauer S; Tarnow L; Stehouwer C; Teerlink T; Baba T; Watanabe T; Parving HH Diabetologia; 2002 Sep; 45(9):1315-24. PubMed ID: 12242465 [TBL] [Abstract][Full Text] [Related]
13. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726 [TBL] [Abstract][Full Text] [Related]
14. Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. van Guldener C; Nanayakkara PW; Stehouwer CD Clin Chem Lab Med; 2007; 45(12):1683-7. PubMed ID: 17937610 [TBL] [Abstract][Full Text] [Related]
15. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia. Spoelstra-de MA; Brouwer CB; Terheggen F; Bollen JM; Stehouwer CD; Smulders YM Neth J Med; 2004; 62(7):246-53. PubMed ID: 15554600 [TBL] [Abstract][Full Text] [Related]
17. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940 [TBL] [Abstract][Full Text] [Related]
18. Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients. Nilsson K; Gustafson L; Hultberg B Dement Geriatr Cogn Disord; 2006; 22(4):358-66. PubMed ID: 16954692 [TBL] [Abstract][Full Text] [Related]
19. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects. Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616 [TBL] [Abstract][Full Text] [Related]
20. The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria. Wotherspoon F; Laight DW; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH Int J Clin Pract; 2008 Apr; 62(4):569-74. PubMed ID: 18248393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]